Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Topline 36-week data from oral small molecule GLP-1 receptor agonist aleniglipron ACCESS and ACCESS II studies on track for readouts by year-end 2025 Oral small molecule amylin receptor agonist ...
SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
NORTH CHARLESTON, S.C. (WCSC) — North Charleston Fire Department crews were out early Monday morning working a reported ...
EAGLE, Idaho — The Eagle Fire Department released safety reminders to the community after responding to report of a structure ...
Reports of a structure fire on Arlington Avenue in Hamilton Reports of a structure fire on Arlington Avenue in Hamilton Reports of a structure fire on Arlington Avenue in Hamilton Reports of a ...
Update at 5:59 a.m. Dec. 1, 2025: Hawai‘i Fire Department reports the fire that happened Sunday (Nov. 30) that involved ...
TUCSON, Ariz. (KVOA) - The Drexel Heights Fire District responded to a report of a structure fire on Tuesday afternoon. On ...
SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback